News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
175,184 Results
Type
Article (12902)
Company Profile (23)
Press Release (162259)
Multimedia
Podcasts (10)
Webinars (5)
Section
Business (48423)
Career Advice (611)
Deals (9064)
Drug Delivery (30)
Drug Development (27922)
Employer Resources (69)
FDA (4668)
Job Trends (3846)
News (90691)
Policy (7803)
Tag
Academia (1072)
Academic (1)
Accelerated approval (1)
Adcomms (6)
Allergies (35)
Alliances (13642)
ALS (38)
Alzheimer's disease (433)
Antibody-drug conjugate (ADC) (22)
Approvals (4675)
Artificial intelligence (64)
Autoimmune disease (8)
Automation (3)
Bankruptcy (70)
Best Places to Work (3194)
BIOSECURE Act (6)
Biosimilars (34)
Biotechnology (11)
Bladder cancer (25)
Brain cancer (8)
Breast cancer (83)
Cancer (605)
Cardiovascular disease (68)
Career advice (514)
Career pathing (13)
CAR-T (46)
Cell therapy (109)
Cervical cancer (9)
Clinical research (23798)
Collaboration (177)
Compensation (15)
Complete response letters (1)
COVID-19 (1082)
CRISPR (9)
C-suite (59)
Cystic fibrosis (20)
Data (779)
Denatured (7)
Depression (10)
Diabetes (98)
Diagnostics (1702)
Digital health (3)
Diversity (5)
Diversity, equity & inclusion (28)
Drug discovery (38)
Drug pricing (39)
Drug shortages (16)
Duchenne muscular dystrophy (32)
Earnings (14323)
Editorial (17)
Employer branding (5)
Employer resources (63)
Events (20851)
Executive appointments (189)
FDA (5022)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (206)
Gene editing (19)
Generative AI (6)
Gene therapy (87)
GLP-1 (273)
Government (1179)
Grass and pollen (2)
Guidances (30)
Healthcare (5369)
Huntington's disease (6)
IgA nephropathy (9)
Immunology and inflammation (33)
Indications (6)
Infectious disease (1128)
Inflammatory bowel disease (56)
Inflation Reduction Act (4)
Influenza (16)
Intellectual property (17)
Interviews (104)
IPO (3424)
IRA (19)
Job creations (772)
Job search strategy (450)
Kidney cancer (2)
Labor market (7)
Layoffs (80)
Leadership (9)
Legal (1523)
Liver cancer (21)
Lung cancer (67)
Lymphoma (42)
Machine learning (2)
Management (22)
Manufacturing (70)
MASH (35)
Medical device (3165)
Medtech (3167)
Mergers & acquisitions (5791)
Metabolic disorders (223)
Multiple sclerosis (41)
NASH (15)
Neurodegenerative disease (22)
Neuropsychiatric disorders (4)
Neuroscience (621)
NextGen: Class of 2025 (1994)
Non-profit (1633)
Obesity (101)
Opinion (47)
Ovarian cancer (16)
Pain (34)
Pancreatic cancer (22)
Parkinson's disease (55)
Partnered (7)
Patents (29)
Patient recruitment (39)
Peanut (17)
People (17262)
Pharmaceutical (11)
Pharmacy benefit managers (9)
Phase I (5269)
Phase II (10232)
Phase III (9702)
Pipeline (334)
Policy (57)
Postmarket research (1147)
Preclinical (1917)
Press Release (29)
Prostate cancer (37)
Psychedelics (9)
Radiopharmaceuticals (62)
Rare diseases (109)
Real estate (1372)
Recruiting (23)
Regulatory (5747)
Reports (13)
Research institute (891)
Resumes & cover letters (82)
Rett syndrome (1)
RSV (18)
Schizophrenia (24)
Series A (48)
Series B (33)
Service/supplier (2)
Sickle cell disease (13)
Special edition (2)
Spinal muscular atrophy (62)
Sponsored (5)
Startups (1178)
Stomach cancer (4)
Supply chain (15)
Tariffs (8)
The Weekly (3)
Vaccines (282)
Venture capitalists (8)
Weight loss (70)
Women's health (15)
Worklife (7)
Date
Today (43)
Last 7 days (205)
Last 30 days (656)
Last 365 days (7924)
2025 (2753)
2024 (8390)
2023 (9558)
2022 (12840)
2021 (14422)
2020 (14001)
2019 (13485)
2018 (10421)
2017 (9476)
2016 (9130)
2015 (10799)
2014 (7356)
2013 (5762)
2012 (6225)
2011 (6605)
2010 (5693)
Location
Africa (252)
Alabama (7)
Alaska (4)
Arizona (42)
Arkansas (2)
Asia (12489)
Australia (2402)
California (1271)
Canada (390)
China (151)
Colorado (51)
Connecticut (49)
Delaware (40)
Europe (33317)
Florida (175)
Georgia (74)
Idaho (14)
Illinois (147)
India (10)
Indiana (88)
Iowa (2)
Japan (72)
Kansas (30)
Kentucky (8)
Louisiana (6)
Maine (11)
Maryland (223)
Massachusetts (854)
Michigan (39)
Minnesota (86)
Missouri (18)
Montana (6)
Nebraska (6)
Nevada (20)
New Hampshire (10)
New Jersey (450)
New Mexico (7)
New York (489)
North Carolina (180)
Northern California (543)
Ohio (41)
Oklahoma (3)
Oregon (4)
Pennsylvania (311)
Puerto Rico (3)
Rhode Island (4)
South America (374)
South Carolina (8)
Southern California (516)
Tennessee (17)
Texas (158)
United States (5020)
Utah (23)
Virginia (27)
Washington D.C. (7)
Washington State (160)
Wisconsin (11)
175,184 Results for "bridgewest group".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Innovative Visionary Mark W. Womack Strengthens Bridgewest Perth Pharma Pty Ltd Board, Amplifying NovaCina’s Growth Vision
Bridgewest Perth Pharma, a global pharmaceutical supply and manufacturing company, with subsidiaries NovaCina and LumaCina, announced the appointment of Mark W. Womack as a Director of the Board.
March 5, 2024
·
3 min read
BioMidwest
Cyrus K. Mirsaidi Named Global CEO to Bridgewest Perth Pharma
Bridgewest Perth Pharma announced that Cyrus K. Mirsaidi is taking the worldwide helm as CEO, including its pharmaceutical supplier division, LumaCina, and its Contract Development and Manufacturing Organization division, NovaCina.
October 24, 2023
·
3 min read
Deals
Bridgewest Group inks deal with Pfizer to acquire injectable manufacturing plant in Western Australia
Global private investment firm, Bridgewest Group, recognized for developing innovative companies in life sciences, software, and deep tech, is expanding its portfolio.
November 11, 2022
·
4 min read
Press Releases
Duchesnay Pharmaceutical Group creates Advisory Board to help guide the Group’s growth and success
April 16, 2025
·
5 min read
Press Releases
Orion Group Interim Report January–March 2025
April 23, 2025
·
6 min read
Press Releases
World Ovarian Cancer Coalition Launches Global Expert Advisory Group on Ovarian Cancer
May 8, 2025
·
4 min read
Press Releases
Sunflower Therapeutics Announces an Exclusive Sales Representation Agreement with Optimal Biotech Group
April 30, 2025
·
3 min read
Press Releases
Olon Group Strengthens Its Leadership in Bioproduction with Two Strategic Appointments in France
April 29, 2025
·
3 min read
Press Releases
Pharming Group to report first quarter 2025 financial results on May 8
April 24, 2025
·
1 min read
Press Releases
Pharming Group reports first quarter 2025 financial results and provides business update
May 8, 2025
·
25 min read
1 of 17,519
Next
